Bangalore Bioinnovation Centre (BBC) is pleased to announce the induction of Biovirexa Lifescience Private Limited into its incubation programme.
Biovirexa Lifescience Private Limited focuses on the development and supply of high-quality Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. With an emphasis on innovation, quality, and regulatory excellence, the company aims to contribute to the advancement of pharmaceutical solutions and the strengthening of the healthcare ecosystem.
Through its incubation at BBC, Biovirexa joins a growing community of innovators working to advance life sciences and healthcare. BBC looks forward to supporting the company's journey and fostering opportunities for collaboration and growth.
Bangalore Bioinnovation Centre extends a warm welcome to Biovirexa Lifescience Private Limited and wishes the team success in its future endeavours.